1-Formyl-3-phenyl-5-(4-isopropylphenyl)-2-pyrazoline: Synthesis, characterization, antimicrobial activity and DFT studies
dc.contributor.author | Sid, Assia | |
dc.contributor.author | Messai, Amel | |
dc.contributor.author | Parlak, Cemal | |
dc.contributor.author | Kazanci, Nadide | |
dc.contributor.author | Luneau, Dominique | |
dc.contributor.author | Kesan, Gurkan | |
dc.contributor.author | Rhyman, Lydia | |
dc.contributor.author | Alswaidan, Ibrahim A. | |
dc.contributor.author | Ramasami, Ponnadurai | |
dc.date.accessioned | 2019-10-27T11:25:22Z | |
dc.date.available | 2019-10-27T11:25:22Z | |
dc.date.issued | 2016 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | The structure of 1-formy1-3-phenyl-5-(4-isopropylpheny1)-2-pyrazoline synthesized as single crystal was investigated by FTIR, NMR, XRD. Experimental data were complemented by quantum mechanical calculations. XRD data show that the compound crystallizes in the triclinic system (P-1) via trans isomer (a = 6.4267(4) angstrom, b = 10.9259(12) angstrom, c = 12.4628(9) angstrom and alpha = 102.894(8)degrees, beta = 102.535(6)degrees, gamma = 101.633(7)degrees). Anti-microbial screening results indicate that the compound shows promising activity. The theoretically predicted and experimentally obtained parameters reveal further insight into pyrazoline systems. (C) 2016 Elsevier B.V. All rights reserved. | en_US |
dc.description.sponsorship | Tassili Programme [15MDU940]; Deanship of Scientific Research at King Saud UniversityScience and Technology Development Fund (STDF) [RGP VPP-207] | en_US |
dc.description.sponsorship | AM and DL acknowledge the Tassili Programme No 15MDU940 for the financial support. The authors are thankful to reviewers for their useful comments to improve the manuscript. The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for the research group Project No. RGP VPP-207. | en_US |
dc.identifier.doi | 10.1016/j.molstruc.2016.05.043 | |
dc.identifier.endpage | 53 | en_US |
dc.identifier.issn | 0022-2860 | |
dc.identifier.issn | 1872-8014 | |
dc.identifier.issn | 0022-2860 | en_US |
dc.identifier.issn | 1872-8014 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 46 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.molstruc.2016.05.043 | |
dc.identifier.uri | https://hdl.handle.net/11454/33381 | |
dc.identifier.volume | 1121 | en_US |
dc.identifier.wos | WOS:000379094100006 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Journal of Molecular Structure | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pyrazolines | en_US |
dc.subject | Crystal structure | en_US |
dc.subject | Hydrogen-bonding | en_US |
dc.subject | Antimicrobial activity | en_US |
dc.title | 1-Formyl-3-phenyl-5-(4-isopropylphenyl)-2-pyrazoline: Synthesis, characterization, antimicrobial activity and DFT studies | en_US |
dc.type | Article | en_US |